Martin Jb Taphoorn
Overview
Explore the profile of Martin Jb Taphoorn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Le Rhun E, Oppong F, van den Bent M, Wick W, Brandes A, Taphoorn M, et al.
Eur J Cancer
. 2022 Nov;
178:13-22.
PMID: 36379185
Background: Thrombocytopenia represents the main cause of stopping alkylating chemotherapy for toxicity. Here, we explored the incidence, and the consequences for treatment exposure and survival, of thrombocytopenia induced by lomustine...
2.
van der Meer P, Dirven L, Fiocco M, Taphoorn M, Koekkoek J
CNS Oncol
. 2020 Jul;
9(2):CNS53.
PMID: 32602750
No abstract available.
3.
Peeters M, Dirven L, Koekkoek J, Numans M, Taphoorn M
CNS Oncol
. 2019 Nov;
8(3):CNS44.
PMID: 31674205
This study aimed to assess the prevalence of symptoms glioma patients may present with to the general practitioner, and whether these can be distinguished from patients with other CNS disorders...
4.
Dirven L, Taphoorn M, Groenvold M, Habets E, Aaronson N, Conroy T, et al.
Neurooncol Pract
. 2019 Aug;
4(3):189-196.
PMID: 31385966
Background: The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group is developing computerized adaptive testing (CAT) versions of each scale of the EORTC Quality of...
5.
Kerkhof M, Tans P, Hagenbeek R, Lycklama A Nijeholt G, Holla F, Postma T, et al.
CNS Oncol
. 2017 Oct;
6(4):297-306.
PMID: 28984142
Aim: We examined whether visual interpretation of relative cerebral blood volume (rCBV) color maps made with dynamic susceptibility-weighted perfusion MRI can reliably distinguish progressive disease (PD) from pseudoprogression (PsPD) in...
6.
Improved, personalized treatment of glioma necessitates long-term follow-up of cognitive functioning
Reijneveld J, Klein M, Taphoorn M, Postma T, Heimans J
Pharmacogenomics
. 2012 Nov;
13(15):1667-9.
PMID: 23171329
No abstract available.
7.
Taphoorn M, Bottomley A
Expert Rev Pharmacoecon Outcomes Res
. 2009 Oct;
5(6):763-74.
PMID: 19807618
Health-related quality of life is increasingly becoming an important end point in cancer research. Until recently, relatively little was known about the health-related quality of life of glioblastoma multiforme patients....
8.
Douw L, Klein M, Fagel S, van den Heuvel J, Taphoorn M, Aaronson N, et al.
Lancet Neurol
. 2009 Aug;
8(9):810-8.
PMID: 19665931
Background: Our previous study on cognitive functioning among 195 patients with low-grade glioma (LGG) a mean of 6 years after diagnosis suggested that the tumour itself, rather than the radiotherapy...